4//SEC Filing
Marques Tiago 4
Accession 0001213900-21-067062
CIK 0001841330other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:00 PM ET
Size
7.4 KB
Accession
0001213900-21-067062
Insider Transaction Report
Form 4
Marques Tiago
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-12-20+200,000→ 800,000 total - Award
Stock Option (to acquire Common Stock)
2021-12-20+200,000→ 200,000 totalExercise: $1.44From: 2022-12-20Exp: 2031-12-20→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted Restricted Stock Units which shall vest into common stock of the Company over three years, subject to Dr. Marques remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches quarterly for two years thereinafter.
- [F2]The Reporting Person was granted 200,000 stock options. The stock options have a ten-year term and vest over three years, subject to Dr. Marques remaining employed and in good standing, one-third vesting 12 months after the grant date, and the remainder vesting in equal tranches quarterly for two years thereinafter.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001875240
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 5:00 PM ET
- Size
- 7.4 KB